Is ZIOP A Good Stock To Buy Now?
In this article we are going to use hedge fund sentiment as a tool and determine whether ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is a good investment right now.
Ziopharm Oncology Inc (ZIOP)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | MSDC Management Marc Lisker, Glenn Fuhrman And John Phelan | 15,151,516 | $27,576 | 1.62% | |
| 2. | Discovery Capital Management Rob Citrone | 12,546,493 | $22,835 | +1% | 1.7% |
| 3. | 7,575,758 | $13,788 | 0.81% | ||
| 4. | Renaissance Technologies Jim Simons | 1,462,487 | $2,662 | +56% | 0% |
| 5. | Point72 Asset Management Steve Cohen | 1,369,900 | $2,493 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.40 | 9,116 | Officer, Director | 885,000 | 2021-11-17 | Filing | |
| $1.40 | 884 | Officer, Director | 875,884 | 2021-11-16 | Filing | |
| $1.91 | 100,000 | Director | 705,321 | 2021-09-29 | Filing | |
| $1.76 | 23,770 | Director | 145,889 | 2021-09-02 | Filing | |
| $1.83 | 50,000 | Director | 120,167 | 2021-09-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.12 | 27,894 | Officer | 199,516 | 2021-01-08 | Filing | |
| $3.09 | 18,020 | Officer | 63,965 | 2021-01-08 | Filing | |
| $3.12 | 26,500 | Officer | 133,319 | 2021-01-08 | Filing | |
| $2.72 | 21,620 | Officer | 206,413 | 2021-01-04 | Filing | |
| $2.71 | 105,693 | Officer, Director | 1,799,280 | 2021-01-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 277,944 | $505,858 | 0% | |
| 2. | 38,790 | $70,598 | 0% | |
| 3. | 16,935,724 | $30,822 | 0% | |
| 4. | 12,643 | $23,000 | 0% | |
| 5. | 12,385,833 | $22,543 | 0% |
News See All
ZIOPHARM Oncology (ZIOP) Has Fallen 47% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks.
ZIOPHARM Oncology Inc. (ZIOP): Are Hedge Funds Right About This Stock?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On ZIOPHARM Oncology Inc. (ZIOP)
Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Hedge Funds Have Never Been More Bullish On ZIOPHARM Oncology Inc. (ZIOP)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.
Do Hedge Funds Love ZIOPHARM Oncology Inc. (ZIOP)?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...
Highlighting ZIOPHARM Oncology Inc. (ZIOP) As A Catalyst Play This Quarter
In Donald Trump’s latest press conference, the President-elect took a swipe at the healthcare and pharmaceutical space, suggesting that drug companies are getting away with murder, and hinting at some...
Should You Avoid ZIOPHARM Oncology Inc. (ZIOP)?
We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks.
5 Stocks Hedge Funds Hate The Most
Insider Monkey keeps a keen eye on the activity of the top hedge funds in the world, as our research has shown that hedge funds’ long positions can deliver market-beating returns.
Billionaire Hedge Funds
